Lv1
20 积分 2025-11-04 加入
Twice-yearly depemokimab demonstrates sustained pharmacokinetics and pharmacodynamics across Phase I and III trials
3个月前
已关闭
Depemokimab PK/PD in the 52-week randomised double-blind multicentre phase III SWIFT-1 trial
3个月前
已完结
Dupilumab for the treatment of asthma
3个月前
已完结
Strategy Aimed at Reduction of Sputum Eosinophils Decreases Exacerbation Rate in Patients with Asthma
3个月前
已完结
Interleukin-18 expression, CD8+ T cells, and eosinophils in lungs of nonsmokers with fatal asthma
3个月前
已关闭
The immunology of asthma
3个月前
已完结
The early history of the eosinophil
3个月前
已完结
Irritant-induced Asthma Caused by Aerotoxic Syndrome
3个月前
已完结
[MRD Testing in Lung Cancer-Latest Insights and Developments]
3个月前
已关闭
Early Reduction of FeNO on Anti‐IL5 Biologics Is Associated With Clinical Remission of Severe Asthma
3个月前
已完结
皖公网安备34019202002308
